Viking Therapeutics

Viking Therapeutics Receives Analyst Rating Update from Investment Bank

Viking Therapeutics (NASDAQ: VKTX) has recently gained renewed attention on Wall Street following a key rating update by a major investment bank. This development is particularly relevant for those doing stock research and monitoring the broader stock market trends in biotech. Viking Therapeutics is a clinical-stage biopharmaceutical company targeting metabolic and endocrine diseases, and its…

Apple

Apple Set for iPhone Sales Boost Thanks to Strong Pro Model Demand

Apple Inc. (NASDAQ: AAPL) is once again making headlines as its latest iPhone 17 Pro models record impressive early sales. According to a recent Reuters report, the company is experiencing a 32% spike in premium iPhone demand compared to last year. This rise is expected to significantly lift its revenue and earnings for the upcoming…